Patients with clonal hematopoiesis have increased heart disease risk following cancer treatment

According to a study published last week in JAMA Oncology by Alex Bick, MD, PhD (Genetic Medicine) and colleagues, patients who have been diagnosed with clonal hematopoiesis of indeterminate potential (CHIP) are at an increased risk for heart disease following cancer treatment.